October 9-11, 2019
Hyatt Regency San Diego, CA, USA 

5th World ADC Awards

The  World ADC Awards showcase the innovation, leadership and devotion shown by the best companies, teams and individuals in the industry.

Ceremony: Tuesday November 13

Now in its 5th year, the World ADC Awards showcase the innovation, leadership and devotion shown by the best companies, teams and individuals in the industry.

Across 9 categories the Awards will recognise the extraordinary endeavours, teamwork and commercial acumen that has propelled the field to the forefront of cancer research today.

The finalists are:

Best ADC Platform Technology (sponsored by Ambrx)
LegoChem Bio (Scaffold Based Approach)
Abzena (Thiobridge)
Mersana (Fleximer)
Bicycle Therapeutics (Bicycles)
Sutro Biopharma (nnAA Conjugation)

Best New Drug Developer
ADC Therapeutics
Mersana
Forbius (Formation Biologics)
Bicycle Therapeutics
Sutro Biopharma
Ambrx

Most Promising Clinical Candidate
Sacituzumab Govitecan (IMMU-132)
Mirvetuximab soravtansine (IMGN853)
Trastuzumab Deruxtecan (DS-8201a)
Rovalpituzumab tesirine (Rova-T)
Polatuzumab Vedotin

Best Contract Manufacturing (CMO) Provider
BSP Pharmaceuticals
Millipore Sigma
Piramal
Novasep
Wuxi Apptec

Best Contract Research (CRO) Provider
Abzena
Menarini
PPD
Charles River
Eurofins Lancaster

Announced on the evening of the Awards:

  • Best Publication 2017
  • Individual Input to the Field 2017
  • Long Standing Contribution to the Field  (sponsored by ImmunoGen)
  • Best Poster 2018

More information can be found at www.worldadc-awards.com

In Partnership with: